Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry
The Life Science industry is standing on the edge of a “patent cliff.” In 2015, the world’s biggest pharmaceutical firms stand to lose up to US$47.5 billion in revenues from the expiry of the patents of some of their biggest blockbuster drugs. For example, Celebrex – an arthritis drug which contribu...
Saved in:
| Main Author: | |
|---|---|
| Format: | text |
| Language: | English |
| Published: |
Institutional Knowledge at Singapore Management University
2015
|
| Subjects: | |
| Online Access: | https://ink.library.smu.edu.sg/soa_research/1653 https://ink.library.smu.edu.sg/context/soa_research/article/2680/viewcontent/Navigating_the.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Singapore Management University |
| Language: | English |
| id |
sg-smu-ink.soa_research-2680 |
|---|---|
| record_format |
dspace |
| spelling |
sg-smu-ink.soa_research-26802018-01-11T07:03:41Z Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry GOH, Clarence The Life Science industry is standing on the edge of a “patent cliff.” In 2015, the world’s biggest pharmaceutical firms stand to lose up to US$47.5 billion in revenues from the expiry of the patents of some of their biggest blockbuster drugs. For example, Celebrex – an arthritis drug which contributed almost US$3 billion to Pfizer’s revenues in 2014 – is set to see its patent expire later this year, opening it up to competition from “generic” alternatives which are often sold at much cheaper prices. 2015-10-01T07:00:00Z text application/pdf https://ink.library.smu.edu.sg/soa_research/1653 https://ink.library.smu.edu.sg/context/soa_research/article/2680/viewcontent/Navigating_the.pdf http://creativecommons.org/licenses/by-nc-nd/4.0/ Research Collection School Of Accountancy eng Institutional Knowledge at Singapore Management University Accounting Corporate Finance |
| institution |
Singapore Management University |
| building |
SMU Libraries |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
SMU Libraries |
| collection |
InK@SMU |
| language |
English |
| topic |
Accounting Corporate Finance |
| spellingShingle |
Accounting Corporate Finance GOH, Clarence Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry |
| description |
The Life Science industry is standing on the edge of a “patent cliff.” In 2015, the world’s biggest pharmaceutical firms stand to lose up to US$47.5 billion in revenues from the expiry of the patents of some of their biggest blockbuster drugs. For example, Celebrex – an arthritis drug which contributed almost US$3 billion to Pfizer’s revenues in 2014 – is set to see its patent expire later this year, opening it up to competition from “generic” alternatives which are often sold at much cheaper prices. |
| format |
text |
| author |
GOH, Clarence |
| author_facet |
GOH, Clarence |
| author_sort |
GOH, Clarence |
| title |
Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry |
| title_short |
Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry |
| title_full |
Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry |
| title_fullStr |
Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry |
| title_full_unstemmed |
Navigating the “patent-cliff”: The role of corporate real estate in the life Science industry |
| title_sort |
navigating the “patent-cliff”: the role of corporate real estate in the life science industry |
| publisher |
Institutional Knowledge at Singapore Management University |
| publishDate |
2015 |
| url |
https://ink.library.smu.edu.sg/soa_research/1653 https://ink.library.smu.edu.sg/context/soa_research/article/2680/viewcontent/Navigating_the.pdf |
| _version_ |
1770573902986084352 |